HARMONi and HARMONi-3 Enrollment Continues
Promising Intracranial Anti-Tumor Activity and Safety Data Featured at the 2024 European Lung Cancer Congress with Ivonescimab Alone or Combined with.
Summit Therapeutics (NASDAQ:SMMT) & VBI Vaccines (NASDAQ:VBIV) Head-To-Head Survey themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Summit Therapeutics Inc. today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief.
SAN DIEGO, April 8, 2024 /PRNewswire/ Akeso, Inc. (9926.HK) today announced that the positive interim analysis results from Phase III clinical study of Cadonilimab (PD-1/CTLA-4 BsAb) combined with XELOX